AstraZeneca Goes for Growth with new Drugs, COVID Sales Wane
Sees solid profit growth in 2023 Sales of blockbuster cancer drugs just below estimates Drugmaker39;s shares have outperformed rivals since 2020 Investor focus on margins in 2023 as operating expenses rise Shares rise more than 4 LONDON, Feb 9 Reuters AstraZeneca on Thursday forecast growth in 2023 earnings and revenue as the British drugmaker seeks to […]